2,4-thiazolidinedione has been researched along with Renal Insufficiency, Chronic in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abushamat, LA | 1 |
| Reusch, JEB | 1 |
1 review available for 2,4-thiazolidinedione and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Evolving Concepts of Type 2 Diabetes Management.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidy | 2021 |